Breast Cancer

Increased state spending on social services such as Medicaid correlated with improved 5-year overall survival among Black adults with cancer, according to study results scheduled for presentation at ASCO Annual Meeting.

The resolution of lymphadenopathy caused by COVID-19 vaccination takes longer than initially suspected, findings showed, but researchers stressed that mammography should not be delayed.

Genetic variants of the UACA gene, a critical regulator of tumor suppressor Par-4, appeared associated with OS among patients who received anthracyclines and HER2-targeted therapy, according to a study published in NPJ Breast Cancer.

Most patients with cancer demonstrated antibody responses to COVID-19 vaccination after two doses of the mRNA-1273 vaccine, according to an observational study published in JAMA Oncology.

Older women with overweight who received cardiotoxic treatment for breast cancer saw a 15% relative CVD risk reduction after following an 8-week time-restricted eating plan, according to research published in JACC: CardioOncology.

HD201, a trastuzumab biosimilar candidate, demonstrated equivalent efficacy to referent trastuzumab among patients with ERBB2-positive early breast cancer, according to phase 3 study results published in JAMA Oncology.

Use of proton beam therapy increased significantly among patients with cancer in the U.S. between 2004 and 2018, but Black individuals had a lower likelihood of receiving the therapy than their white counterparts.

SAN DIEGO — Black women continue to experience disparities in breast cancer diagnosis and treatment, leading to increased mortality.

The FDA expanded the approval of fam-trastuzumab deruxtecan to include treatment of patients with HER2-positive metastatic breast cancer who received a prior anti-HER2-based regimen.

The FDA recently granted breakthrough therapy designation of a HER2-directed antibody drug conjugate for the treatment of certain adults with unresectable or metastatic HER2-low breast cancer.